NeOnc Technologies (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- February 08, 2023
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Valuation
- $70,000,000
- Funding Amount:
- $10,000,000
Company Info
- Founders
- Thomas Chen
- Company Description
- NeOnc Technologies develops intranasal inhalation dosing therapies for the treatment of brain and lung cancers.
- Market
- Pharmaceuticals and therapeutics for brain and central nervous system diseases
- Location
- Los Angeles, CA, USA
- Coinvestors
- Eminent II Venture Capital, Lin Family Office, Orion BioScience